Greuter Ladina, Hejrati Nader, Soleman Jehuda
Department of Neurosurgery, University Hospital of Basel, Basel, Switzerland.
Faculty of Medicine, University of Basel, Basel, Switzerland.
Front Neurol. 2020 Apr 22;11:312. doi: 10.3389/fneur.2020.00312. eCollection 2020.
Chronic subdural hematoma (cSDH) is one of the most common neurosurgical diseases, while burr-hole drainage is the most frequently used surgical treatment. Strong evidence exists that subdural drain (SDD) placement reduces recurrence rates. However, the insertion of a subperiosteal drain (SPD) was shown to lead to similar recurrence rates and less complications than SDD. The aim of this study is to provide a systematic review of the literature and conduct a meta-analysis of studies comparing SPD with SDD after burr-hole drainage of cSDH. Pubmed and Embase databases were searched using a systematic search strategy to identify studies on drain location up to December 2019. Two independent researchers assessed the studies for inclusion and quality. Primary outcome measure was recurrence, while secondary outcome measures were drain misplacement, morbidity, mortality, and clinical outcome. Besides randomized controlled trials (RCT), we included non-randomized prospective cohort studies, as well as retrospective cohort studies. A fixed effects model was used if low heterogeneity ( < 50%) was present, otherwise a random effects model was used. Following removal of duplicates, we screened 1109 articles of which 10 articles were included in our qualitative and quantitative analyses. One study was an RCT, three were non-randomized prospective cohort studies, and the remaining articles were retrospective cohort studies or subgroup analysis. In these 10 articles, 1,553 patients were treated with SPD and 1782 patients with SDD. Comparing the recurrence rate of cSDH a significant difference was found between SPD and SDD insertion (11.9 and 12.3%; RR 0.8, 95% CI 0.67-0.97, = 0%, z = -2.27, = 0.02). SPD had significantly lower rates of drain misplacement and parenchymal injuries (1.2 and 7.8%; RR 0.17, 95% CI 0.07-0.42, = 0%, z = -3.4, = 0.0001), as well as morbidity (6.4 and 8.2%; RR 0.65, 95% CI 0.5-0.84, = 44.5%, z = -3.32, =0.0009). Mortality rates (5.0 and 4.6%; RR 0.83, 95% CI 0.6-1.14, = 0%, z = -1.2, = 0.25) and favorable clinical outcome (89.6 and 88.9%; RR 1.1, 95% CI 0.89-1.24, = 54.2%, = 0.98, = 0.40) were comparable in both groups. The insertion of SPD after burr-hole drainage of cSDH showed lower rates of recurrence, drain misplacements and parenchymal injuries, as well as overall morbidity, while clinical outcome and mortality were comparable to SDD. Therefore, the insertion of SPD after surgical drainage of cSDH should be encouraged.
慢性硬膜下血肿(cSDH)是最常见的神经外科疾病之一,而钻孔引流是最常用的外科治疗方法。有强有力的证据表明,放置硬膜下引流管(SDD)可降低复发率。然而,研究表明,与SDD相比,骨膜下引流管(SPD)的置入导致的复发率相似且并发症更少。本研究的目的是对文献进行系统综述,并对cSDH钻孔引流术后比较SPD与SDD的研究进行荟萃分析。使用系统检索策略在Pubmed和Embase数据库中进行检索,以识别截至2019年12月关于引流管位置的研究。两名独立研究人员评估纳入研究及其质量。主要结局指标是复发率,次要结局指标是引流管误置、发病率、死亡率和临床结局。除随机对照试验(RCT)外,我们还纳入了非随机前瞻性队列研究以及回顾性队列研究。如果异质性较低(<50%),则使用固定效应模型,否则使用随机效应模型。在去除重复项后,我们筛选了1109篇文章,其中10篇文章纳入了我们的定性和定量分析。1项研究为RCT,3项为非随机前瞻性队列研究,其余文章为回顾性队列研究或亚组分析。在这10篇文章中,1553例患者接受了SPD治疗,1782例患者接受了SDD治疗。比较cSDH的复发率,发现SPD与SDD置入之间存在显著差异(分别为11.9%和12.3%;RR 0.8,95%CI 0.67 - 0.97,I² = 0%,z = -2.27,P = 0.02)。SPD的引流管误置率和脑实质损伤率显著更低(分别为1.2%和7.8%;RR 0.17,95%CI 0.07 - 0.42,I² = 0%,z = -3.4,P = 0.0001),发病率也更低(分别为6.4%和8.2%;RR 0.65,95%CI 0.5 - 0.84,I² = 44.5%,z = -3.32,P = 0.0009)。两组的死亡率(分别为5.0%和4.6%;RR 0.83,95%CI 0.6 - 1.14,I² = 0%,z = -1.2,P = 0.25)和良好临床结局(分别为89.6%和88.9%;RR 1.1,95%CI 0.89 - 1.24,I² = 54.2%,P = 0.98,df = 0.40)相当。cSDH钻孔引流术后置入SPD显示出更低的复发率、引流管误置率和脑实质损伤率,以及总体发病率,而临床结局和死亡率与SDD相当。因此,应鼓励在cSDH手术引流后置入SPD。